-
1
-
-
70350334557
-
Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes by long-term administration of a palatinose-based liquid formula as a part of breakfast
-
Sakuma M, Arai H, Mizuno A, Fukaya M, Matsuura M, Sasaki H, Yamanaka-Okumura H, Yamamoto H, Taketani Y, Doi T, Takeda E: Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes by long-term administration of a palatinose-based liquid formula as a part of breakfast. J Clin Biochem Nutr 2009; 45:155-162
-
(2009)
J. Clin. Biochem. Nutr.
, vol.45
, pp. 155-162
-
-
Sakuma, M.1
Arai, H.2
Mizuno, A.3
Fukaya, M.4
Matsuura, M.5
Sasaki, H.6
Yamanaka-Okumura, H.7
Yamamoto, H.8
Taketani, Y.9
Doi, T.10
Takeda, E.11
-
2
-
-
17744410408
-
Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in longterm care residents with type 2 diabetes: Results of a pilot trial
-
Craig LD, Nicholson S, Silverstone FA, Kennedy RD: Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in longterm care residents with type 2 diabetes: results of a pilot trial. Nutrition 1998;14:529-534
-
(1998)
Nutrition
, vol.14
, pp. 529-534
-
-
Craig, L.D.1
Nicholson, S.2
Silverstone, F.A.3
Kennedy, R.D.4
-
3
-
-
24144438663
-
Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: A systematic review and meta-analysis
-
Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ: Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care 2005;28:2267-2279
-
(2005)
Diabetes Care
, vol.28
, pp. 2267-2279
-
-
Elia, M.1
Ceriello, A.2
Laube, H.3
Sinclair, A.J.4
Engfer, M.5
Stratton, R.J.6
-
4
-
-
0344064140
-
Isoleucine a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes
-
Doi M, Yamaoka I, Fukunaga T: Isoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes. Biochem Biophys Res Commun 2003;312: 1111-1117
-
(2003)
Biochem. Biophys. Res. Commun.
, vol.312
, pp. 1111-1117
-
-
Doi, M.1
Yamaoka, I.2
Fukunaga, T.3
-
5
-
-
41149142315
-
Acute and chronic treatment of l-isoleucine ameliorates glucose metabolism in glucose-intolerant and diabetic mice
-
Ikehara O, Kawasaki N, Maezono K, Komatsu M, Konishi A: Acute and chronic treatment of l-isoleucine ameliorates glucose metabolism in glucose-intolerant and diabetic mice. Biol Pharm Bull 2008;31:469-472
-
(2008)
Biol. Pharm. Bull.
, vol.31
, pp. 469-472
-
-
Ikehara, O.1
Kawasaki, N.2
Maezono, K.3
Komatsu, M.4
Konishi, A.5
-
6
-
-
84863786213
-
The effect of glycemic control and the decrease of malnutrition after intake of the new diabetic enteral diet DM-1 in diabetic rats in Japanese
-
Fujimaki M, Hayashi N, Kokuba Y: The effect of glycemic control and the decrease of malnutrition after intake of the new diabetic enteral diet, ''DM-1'' in diabetic rats [in Japanese]. Jomyakukeichoeiyo 2011;85:955-961
-
(2011)
Jomyakukeichoeiyo
, vol.85
, pp. 955-961
-
-
Fujimaki, M.1
Hayashi, N.2
Kokuba, Y.3
-
7
-
-
84863793646
-
Effect of enteral nutrition formula containing l-isoleucine DM-1 on glycemic control in elderly patients with abnormal glucose tolerance in Japanese
-
Fukushima R, Hasebe M, Morita N, Taniguchi M, Takada K, Motomiya H, Oizumi A, Shikoshi A, Kaneko M, Tanaka Y: Effect of enteral nutrition formula containing l-isoleucine (DM-1) on glycemic control in elderly patients with abnormal glucose tolerance [in Japanese]. Jomyakukeichoeiyo 2011;26:757-763
-
(2011)
Jomyakukeichoeiyo
, vol.26
, pp. 757-763
-
-
Fukushima, R.1
Hasebe, M.2
Morita, N.3
Taniguchi, M.4
Takada, K.5
Motomiya, H.6
Oizumi, A.7
Shikoshi, A.8
Kaneko, M.9
Tanaka, Y.10
-
8
-
-
77954804860
-
Glycemic variability: Thethird component of the dysglycemia in diabetes is it important how to measure it
-
Monnier L, Colette C, Owens DR: Glycemic variability: thethird component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2008; 2:1094-1100
-
(2008)
J. Diabetes. Sci. Technol.
, vol.2
, pp. 1094-1100
-
-
Monnier, L.1
Colette, C.2
Owens, D.R.3
-
9
-
-
2942574527
-
Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type s1 diabetes mellitus using a basal-bolus regimen
-
Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J: Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type-s1 diabetes mellitus using a basal-bolus regimen. Clin Ther 2004;26:724-736
-
(2004)
Clin. Ther.
, vol.26
, pp. 724-736
-
-
Russell-Jones, D.1
Simpson, R.2
Hylleberg, B.3
Draeger, E.4
Bolinder, J.5
-
10
-
-
0014848738
-
Mean amplitude of glycemic excursions a measure of diabetic instability
-
Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19: 644-655
-
(1970)
Diabetes
, vol.19
, pp. 644-655
-
-
Service, F.J.1
Molnar, G.D.2
Rosevear, J.W.3
Ackerman, E.4
Gatewood, L.C.5
Taylor, W.F.6
-
11
-
-
77956069166
-
Hypoglycemia diabetes and cardiovascular events
-
Desouza CV, Bolli GB, Fonseca V: Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010;33:1389-1394
-
(2010)
Diabetes Care
, vol.33
, pp. 1389-1394
-
-
Desouza, C.V.1
Bolli, G.B.2
Fonseca, V.3
-
12
-
-
84872210150
-
-
International Diabetes Federation accessed February
-
International Diabetes Federation: Guideline for Management of Postmeal Glucose. www.idf.org/guidelines/ postmeal-glucose (accessed February 8, 2012).
-
(2012)
Guideline for Management of Postmeal Glucose
, vol.8
-
-
-
13
-
-
61849122401
-
One-year comparison of a highmonounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes
-
Brehm BJ, Lattin BL, Summer SS, Boback JA, Gilchrist GM, Jandacek RJ, D'Alessio DA: One-year comparison of a highmonounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes. Diabetes Care 2009;32:215-220
-
(2009)
Diabetes Care
, vol.32
, pp. 215-220
-
-
Brehm, B.J.1
Lattin, B.L.2
Summer, S.S.3
Boback, J.A.4
Gilchrist, G.M.5
Jandacek, R.J.6
D'Alessio, D.A.7
-
14
-
-
34447574828
-
Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis
-
Doi M, Yamaoka I, Nakayama M, Sugahara K, Yoshizawa F: Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 2007;292:E1683-E1693
-
(2007)
Am. J. Physiol. Endocrinol. Metab.
, vol.292
-
-
Doi, M.1
Yamaoka, I.2
Nakayama, M.3
Sugahara, K.4
Yoshizawa, F.5
|